Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapyInvivoscribe Marketing2021-02-11T20:11:02-08:00October 8th, 2020|2020 Publications, Publications| Read more
Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtypeInvivoscribe Marketing2021-02-11T20:13:51-08:00August 27th, 2020|2020 Publications, Publications| Read more
Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessmentInvivoscribe Marketing2021-02-11T20:26:38-08:00July 22nd, 2020|2020 Publications, Publications| Read more
Evaluation of the polymerase chain reaction–based T-cell receptor β clonality test in the diagnosis of early mycosis fungoidesInvivoscribe Marketing2021-02-11T21:43:52-08:00June 8th, 2020|2020 Publications, Publications| Read more
Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation SequencingInvivoscribe Marketing2021-02-11T21:47:46-08:00May 19th, 2020|2020 Publications, Publications| Read more
Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatmentInvivoscribe Marketing2021-02-15T19:48:14-08:00May 6th, 2020|2020 Publications, Publications| Read more
Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple MyelomaInvivoscribe Marketing2021-02-11T21:50:38-08:00May 1st, 2020|2020 Publications, Publications| Read more
Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV statusInvivoscribe Marketing2021-02-11T21:53:32-08:00April 1st, 2020|2020 Publications, Publications| Read more
Quantitation of CMV Specific T-Cell Expansion Using T Cell Receptor Beta Locus Deep Sequencing to Identify Patients at Risk of Viral ComplicationsInvivoscribe Marketing2021-02-11T21:56:18-08:00March 1st, 2020|2020 Publications, Publications| Read more
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patientsInvivoscribe Marketing2021-02-11T21:58:45-08:00February 6th, 2020|2020 Publications, Publications| Read more
Monitoring minimal residual disease in the bone marrow using next generation sequencingInvivoscribe Marketing2021-02-11T22:00:56-08:00January 17th, 2020|2020 Publications, Publications| Read more
Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a “Spike-in” Clonal SequenceInvivoscribe Marketing2021-02-11T23:36:10-08:00November 13th, 2019|2019 Publications, Publications| Read more
Clonally-Related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implicationsInvivoscribe Marketing2021-02-11T23:40:44-08:00October 15th, 2019|2019 Publications, Publications| Read more
Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myelomaInvivoscribe Marketing2021-02-11T23:43:09-08:00October 1st, 2019|2019 Publications, Publications| Read more
Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple MyelomaInvivoscribe Marketing2021-02-15T20:01:10-08:00June 6th, 2019|2019 Publications, Publications| Read more
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell NeoplasmsInvivoscribe Marketing2021-02-11T23:46:14-08:00March 21st, 2019|2019 Publications, Featured Publications, Publications| Read more
A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutationsInvivoscribe Marketing2021-02-11T23:49:39-08:00August 25th, 2018|2018 Publications, Featured Publications, Publications| Read more
Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALLInvivoscribe Marketing2021-02-11T23:54:51-08:00August 22nd, 2018|2018 Publications, Featured Publications, Publications| Read more
Clinical-scale Rapid Autologous BK-virus Specific T Cell Line generation from Kidney Transplant Recipients with Active Viremia for Adoptive ImmunotherapyInvivoscribe Marketing2021-02-12T21:23:31-08:00November 11th, 2017|2017 Publications, Publications| Read more
Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)Invivoscribe Marketing2021-02-12T00:14:15-08:00August 9th, 2017|2017 Publications, Publications| Read more
Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic LeukemiaInvivoscribe Marketing2021-02-12T00:59:47-08:00July 3rd, 2017|2017 Publications, Publications| Read more
In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosisInvivoscribe Marketing2021-02-12T01:06:38-08:00June 20th, 2017|2017 Publications, Publications| Read more
Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patientsInvivoscribe Marketing2021-02-12T00:57:59-08:00June 17th, 2017|2017 Publications, Publications| Read more
T and B cell clonal expansion in Ras associated lymphoproliferative disease (RALD) as revealed by next generation sequencingInvivoscribe Marketing2021-02-12T00:17:56-08:00May 30th, 2017|2017 Publications, Publications| Read more
Molecular pathology diagnosis of diffuse large B cell lymphoma using BIOMED-2 clonal gene rearrangementsInvivoscribe Marketing2021-02-12T01:03:26-08:00April 27th, 2017|2017 Publications, Publications| Read more